Impact BioMedical, INC. (IBO)

Every figure this model derived for IBO, the value it took, and the element in the company's own XBRL it was read from — so any of it can be checked against the filing rather than taken on trust. As at 2026-06-30.

The figures, and where each came from

This is the part no other screener shows. Each figure below names the XBRL element it was read from, so it can be checked against the filing itself.

FigureValueXBRL tagAs at
cash 20,000 CashAndCashEquivalentsAtCarryingValue 2026-03-31
current assets 320,000 AssetsCurrent 2026-06-30
current liabilities 2,045,000 LiabilitiesCurrent 2026-06-30
equity 10,766,000 StockholdersEquity 2026-06-30
interest expense 793,000 InterestExpense 2025-12-31
ocf -508,000 NetCashProvidedByUsedInOperatingActivities 2026-06-30
revenue 35,000 RevenueFromContractWithCustomerExcludingAssessedTax 2026-06-30
sbc 1,449,000 ShareBasedCompensation 2026-06-30

The ratios

The figures themselves rather than their scores — what somebody looking up IBO on one particular measure came for.

RatioValue
current ratio0.16
current ratio reported0.16
dilution pct193.51
fcf margin-1451.43
interest cover-6.44
roic-37.56

What to be careful about

What this model itself distrusts about IBO's figures. Written by the derivation as it ran, not added afterwards.